Fabrication and Computational Study of pH-Responsive Chitosan/Poly(HEMA-co-2-HMBA) Microparticles for Controlled, Site-Specific Doxorubicin Delivery
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262110460 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sivagangi Reddy Nagella und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Polymer Science and Engineering, Pusan National University, Busan 46241, Republic of Korea. Hauptthemen laut MEDLINE: Doxorubicin, Chitosan, Drug Carriers, Drug Delivery Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education.
Abstract (Originalsprache)
As a chitosan (CTS)-based drug carrier (DC) for doxorubicin (DOX) delivery, poly(2-hydroxyethyl methacrylate-co-2-hydroxy-4-N-methacrylamidobenzoic acid) [poly(HEMA-co-2-HMBA)] (PHCH) was successfully grafted onto chitosan to fabricate DOX-loaded microparticles, and their in vitro release behavior was systematicaly investigated. Morphological characteristics were analyzed using scanning electron microscopy (SEM) and transmission electron microscopy (TEM), while DOX loading was validated through Fourier-transform infrared (FTIR) spectroscopy and thermogravimetric analysis (TGA), comparing pure and drug-loaded microparticles. The maximum loading capacity (~91%) was attributed to the presence of abundant carboxylic acid groups, which imparted pH responsiveness during in vitro DOX release. Furthermore, density functional theory (DFT) calculations revealed that hydrogen bonding interactions between DOX and the functional groups of the microparticles strongly influenced encapsulation efficiency (EE%), drug loading (DL%), and release behavior. The fabricated microparticles exhibited pH-dependent DOX release, with accelerated and more complete release at tumor microenvironment pH 5.5 compared to physiological pH 7.4. These results demonstrate that PHCH grafted CTS microparticles are promising candidates for controlled and site-specific anticancer drug delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Polymer Science and Engineering, Pusan National University, Busan 46241, Republic of Korea.
- Department of Nanoenergy Engineering, Pusan National University, Busan 46241, Republic of Korea.
- Department of Surgery, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Yangsan 50621, Republic of Korea.
- Research Institute of Industrial Technology, Pusan National University, Busan 46241, Republic of Korea.
ORCID-Profile: Sivagangi Reddy Nagella, Ramesh Kumar Chitumalla, Joonkyung Jang, Ildoo Chung
Förderung
- National Research Foundation of Korea
- Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education
Zitieren
APA
Nagella, S. R., Chitumalla, R. K., Choi, J., Jang, J., Seo, H. I., & Chung, I. (2025). Fabrication and Computational Study of pH-Responsive Chitosan/Poly(HEMA-co-2-HMBA) Microparticles for Controlled, Site-Specific Doxorubicin Delivery. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110460
Vancouver
Nagella SR, Chitumalla RK, Choi J, Jang J, Seo HI, Chung I. Fabrication and Computational Study of pH-Responsive Chitosan/Poly(HEMA-co-2-HMBA) Microparticles for Controlled, Site-Specific Doxorubicin Delivery. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110460
BibTeX
@article{Nagella2025,
author = {Nagella, Sivagangi Reddy and Chitumalla, Ramesh Kumar and Choi, Jiun and Jang, Joonkyung and Seo, Hyung Il and Chung, Ildoo},
title = {Fabrication and Computational Study of pH-Responsive Chitosan/Poly(HEMA-co-2-HMBA) Microparticles for Controlled, Site-Specific Doxorubicin Delivery},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262110460}
}
EUVIMED